• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.

作者信息

Berkowitz D

出版信息

Am J Dig Dis. 1969 Oct;14(10):691-9. doi: 10.1007/BF02233575.

DOI:10.1007/BF02233575
PMID:4898689
Abstract
摘要

相似文献

1
Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.
Am J Dig Dis. 1969 Oct;14(10):691-9. doi: 10.1007/BF02233575.
2
[Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].[肝硬化碳水化合物代谢的动态探索。血液中游离脂肪酸和胰岛素的测定]
Sem Hop. 1972 Mar 20;48(14):957-66.
3
[Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].[肝硬化患者葡萄糖和甲苯磺丁脲负荷后的代谢变化及其在肝源性糖尿病发病机制中的作用]
Klin Wochenschr. 1970 Nov 1;48(21):1265-76. doi: 10.1007/BF01485518.
4
Plasma insulin response to oral glucose load in hepatic cirrhosis.肝硬化患者口服葡萄糖负荷后的血浆胰岛素反应
Indian J Med Res. 1983 Sep;78:388-94.
5
[Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].[肝硬化患者静脉注射甲苯磺丁脲后血浆/胰岛素、生长激素和游离脂肪酸的变化]
Minerva Med. 1976 Nov 10;67(54):3525-32.
6
Clinical investigation on abnormal glucose tolerance in liver cirrhosis.
Gastroenterol Jpn. 1976;11(1):31-7. doi: 10.1007/BF02775448.
7
[The pathogenesis of hepatogenic diabetes mellitus].[肝源性糖尿病的发病机制]
Klin Wochenschr. 1970 Nov 1;48(21):1259-65. doi: 10.1007/BF01485517.
8
[Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].[酒精性肝硬化患者口服葡萄糖耐量试验后血浆胰岛素和生长激素的测定]
Arch Fr Mal App Dig. 1974 Jan-Feb;63(1):17-24.
9
Insulin response in chronic alcoholism.慢性酒精中毒中的胰岛素反应。
Lancet. 1968 Jan 20;1(7534):145. doi: 10.1016/s0140-6736(68)92757-8.
10
Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.慢性肝硬化患者的血清葡萄糖、胰岛素和生长激素
Arch Intern Med. 1969 Aug;124(2):149-52.

引用本文的文献

1
Oridonin prevents insulin resistance-mediated cognitive disorder through PTEN/Akt pathway and autophagy in minimal hepatic encephalopathy.冬凌草甲素通过 PTEN/Akt 通路和自噬预防轻微型肝性脑病中胰岛素抵抗介导的认知障碍。
J Cell Mol Med. 2020 Jan;24(1):61-78. doi: 10.1111/jcmm.14546. Epub 2019 Sep 30.
2
Nature and quantity of fuels consumed in patients with alcoholic cirrhosis.酒精性肝硬化患者所消耗燃料的性质和数量。
J Clin Invest. 1983 Nov;72(5):1821-32. doi: 10.1172/JCI111142.
3
Possible roles of insulin, glucagon, growth hormone and free fatty acids in the pathogenesis of insulin resistance of subjects with chronic liver diseases.

本文引用的文献

1
Exocrine and endocrine pancreatic function in diabetes mellitus and chronic pancreatitis.糖尿病和慢性胰腺炎中的胰腺外分泌和内分泌功能
Gut. 1966 Jun;7(3):277-81. doi: 10.1136/gut.7.3.277.
2
Studies in hepatic glycogen storage; adrenalin-induced hyperglycemia as an index of liver function.肝脏糖原储存的研究；肾上腺素诱导的高血糖作为肝功能指标
Am J Med Sci. 1949 May;217(5):554-62.
3
The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma.人胰岛细胞腺瘤中胰岛素及胰岛素可能前体的生物合成。
胰岛素、胰高血糖素、生长激素及游离脂肪酸在慢性肝病患者胰岛素抵抗发病机制中的可能作用。
Acta Diabetol Lat. 1984 Jul-Sep;21(3):241-50. doi: 10.1007/BF02642897.
4
Serum levels of true insulin, C-peptide and proinsulin in peripheral blood of patients with cirrhosis.肝硬化患者外周血中真胰岛素、C肽和胰岛素原的血清水平。
Diabetologia. 1983 Dec;25(6):506-9. doi: 10.1007/BF00284460.
5
Glucose tolerance and insulin secretion in patients with chronic duodenal ulcer.慢性十二指肠溃疡患者的葡萄糖耐量和胰岛素分泌
Br Med J. 1972 Nov 18;4(5837):393-6. doi: 10.1136/bmj.4.5837.393.
6
Behavior of pancreatic glucagon, insulin, and HGH in liver cirrhosis, after arginine and I.V. glucose.肝硬化患者在输注精氨酸和静脉注射葡萄糖后，胰腺胰高血糖素、胰岛素和生长激素的变化情况
Acta Diabetol Lat. 1974 Jul-Aug;11(4):330-9. doi: 10.1007/BF02581236.
7
A study of carbohydrate metabolism in postnecrotic cirrhosis liver.坏死性肝硬化肝脏中碳水化合物代谢的研究。
Gut. 1974 Nov;15(11):907-12. doi: 10.1136/gut.15.11.907.
8
Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.人类肝硬化中胰岛素抵抗的机制。受体与受体后联合缺陷的证据。
J Clin Invest. 1985 May;75(5):1659-65. doi: 10.1172/JCI111873.
9
Glucose, insulin and C-peptide kinetics during an oral glucose tolerance test in patients with chronic liver disease.慢性肝病患者口服葡萄糖耐量试验期间的葡萄糖、胰岛素和C肽动力学。
Korean J Intern Med. 1987 Jan;2(1):37-41. doi: 10.3904/kjim.1987.2.1.37.
10
C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.非酒精性肝硬化和肝细胞癌中的C肽
J Endocrinol Invest. 1988 May;11(5):337-43. doi: 10.1007/BF03349051.
Proc Natl Acad Sci U S A. 1967 Feb;57(2):473-80. doi: 10.1073/pnas.57.2.473.
4
Net splanchnic glucose production in normal man and in various disease states.正常人及各种疾病状态下的内脏葡萄糖净生成量。
J Clin Invest. 1950 Nov;29(11):1421-9. doi: 10.1172/JCI102380.
5
Plasma free fatty acid in liver disease.肝脏疾病中的血浆游离脂肪酸
Gut. 1961 Dec;2(4):304-9. doi: 10.1136/gut.2.4.304.
6
INSULIN REGULATORY MECHANISMS AND DIABETES MELLITUS.胰岛素调节机制与糖尿病
Diabetes. 1964 May-Jun;13:230-40.
7
INFLUENCE OF FREE-FATTY-ACID METABOLISM ON GLUCOSE TOLERANCE.游离脂肪酸代谢对葡萄糖耐量的影响。
Lancet. 1964 Jul 18;2(7351):115-7. doi: 10.1016/s0140-6736(64)90125-4.
8
EFFECTS OF FAT INFUSION ON GLUCOSE TOLERANCE AND INSULIN PLASMA LEVELS.脂肪输注对葡萄糖耐量和胰岛素血浆水平的影响。
Med Exp Int J Exp Med. 1964;10:153-6. doi: 10.1159/000135410.
9
THE "TYPICAL" AND "ATYPICAL" FORMS OF SERUM INSULIN.血清胰岛素的“典型”和“非典型”形式。
Diabetes. 1963 Jul-Aug;12:339-48. doi: 10.2337/diab.12.4.339.
10
[Intravenous injections of glucose, insulin and tolbutamide in healthy persons, diabetics, cirrhotics, and patients with insuloma (together with a contribution on the diagnostic value of the tolbutamide tests)].[健康人、糖尿病患者、肝硬化患者及胰岛素瘤患者静脉注射葡萄糖、胰岛素和甲苯磺丁脲（附甲苯磺丁脲试验诊断价值的探讨）]
Dtsch Med Wochenschr. 1962 Oct 26;87:2189-95. doi: 10.1055/s-0028-1114074.